IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q2 2018 Holdings

Filed 2018-08-14 | 3 holdings | $92.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aegerion Pharmaceuticals IncNOTE 2.000% 8/100767EAB8$62.6K$95,045,00067.7%
PTC Therapeutics IncNOTE 3.000% 8/169366JAB7$28.1K$28,067,00030.4%
Apollo Endosurgery Inc(HQ8F)COM03767D108$1.8K252,0791.9%